Clinical Trial Update: To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing patient preference between Movantik (naloxegol) and polyethylene glycol 3350 for opioid-induced constipation; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• MOVANTIK (Naloxegol oxalate)
• Polyethylene glycol 3350 (polyethylene glycol 3350)

Snippet

Sponsor: AstraZeneca | Conditions: Opioid Induced Constipation | Phase 4 | Status: COMPLETED | Results posted: 2018-07-13